Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof

A recombinant adenovirus, respiratory syndrome technology, applied in respiratory diseases, botanical equipment and methods, biochemical equipment and methods, etc., can solve the expression imbalance, the mutual interference of promoters, the different properties of natural proteins, etc. problem, to achieve the effect of stable potency

Inactive Publication Date: 2009-03-11
ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES
View PDF0 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these strategies have some defects, such as the low initial efficiency of the expressed gene, the serious imbalance between the expression of the upstream gene and the downstream gene, mutual interference between the promoters, and the nature of the expressed protein is not the same as that of the natural protein, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof
  • Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof
  • Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Embodiment 1: (preparation method of porcine reproductive and respiratory syndrome bivalent recombinant adenovirus vaccine)

[0058] The preparation of the vaccine is carried out in the following steps:

[0059] (1) Construction of GP5-2A-M fusion protein gene:

[0060] 1.1 Design and synthesis of PCR primers: According to the gene sequences of PRRSV American standard strain ATCC VR-2332 and FMDVChina / 99 type O strain, a pair of specific primers for GP5, M and 2A genes of PRRSV domestic isolate NB / 04 strain were designed respectively. Sex fusion primers, the primer sequences are as follows:

[0061] AdGP5: 5'-CGC GGT ACC CCA CCATGG TGG GGA AAT GCT TG-3'

[0062] AdGP5-2A:5'-AAC GTC TCC TGC TAA CTT CAA AAG ATC AAA GTT CGT GAG

[0063] ACG ACC CCA-3'

[0064] AdM-2A:5'-TTA GCA GGA GAC GTT GAG TCC AAC CCC GGA CCC ATG GGG TCG

[0065] TCT CTA-3'

[0066] AdM:5'-TAT GCG GCC GCT TAT TTG GCA TAT TTA AC-3'

[0067] 1.2 NB / 04 strain infection of Marc-145 cells and extract...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a porcine reproductive and respiratory syndrome divalent recombination adenovirus vaccine and the preparation method thereof. The invention belongs to the technical field of biological vaccine preparation. The vaccine can be prepared by the following steps: a GP5-2A-M fusion protein gene can be constructed by inserting an FMDV2A gene with self craking between PRRSV GP5 and M protein; homologous recombination is carried out on the GP5-2A-M fusion protein gene and adenovirus backbone plasmid pAdEasy-1; recombination adenovirus rAd-GP5-2A-M is prepared by restriction enzyme and HEK-293A cells transfection, and the divalent recombination adenovirus vaccine is prepared by the technology and the steps such as purification, amplification, and the like. After expression, the aggregate protein GP5-2A-M constructed by the invention is self cracked into GP5 and M protein, as well as exerts the viral neutralization of GP5 and the immune function of the M protein; the vaccine has stable titer with the virulent valence being 10<10.43>TCID<50>/1.0ml, as well as has both the duplication characteristic of a routine attenuated vaccine and the safety of an inactivated vaccine; the divalent recombination adenovirus vaccine can be popularized in and applied to the control work of porcine reproductive and respiratory syndrome.

Description

technical field [0001] The invention belongs to the technical field of biological vaccines, in particular to a bivalent recombinant adenovirus vaccine for immune protection against porcine reproductive and respiratory syndrome and a preparation method thereof. technical background [0002] Porcine reproductive and respiratory syndrome (porcine reproductive and respiratory syndrome, PRRS) is caused by porcine reproductive and respiratory syndrome virus (PRRSV). Infectious disease characterized by high mortality. [0003] Since it was first reported in North America in 1987, it has spread to almost all countries and regions with developed swine industry in the world, causing huge economic losses to the pig industry and its product trade, and has become one of the main viral diseases in the pig industry. one. The disease broke out in my country at the end of 1995, and then spread rapidly to most provinces in the country. In recent years, the PRRS epidemic has aggravated agai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/12C12N15/62C12N15/861C12N7/01C12N7/02A61P31/12A61P15/00A61P11/00
Inventor 刘光清云涛倪征余斌陈柳华炯钢李双茂
Owner ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products